Circulating tumor cells count predicts survival in colorectal cancer patients

Adriana Romiti; Salvatore Raffa; Roberta Di Rocco; Michela Roberto; Annalisa Milano; Angelo Zullo; Laura Leone; Danilo Ranieri; Francesca Mazzetta; Emanuela Medda; Ida Sarcina; Viola Barucca; Chiara D'Antonio; Valeria Durante; Mario Ferri; Maria Rosaria Torrisi; Paolo Marchetti

doi:10.1543/jgld.2014.1121

Circulating tumor cells count predicts survival in colorectal cancer patients

Adriana Romiti, Salvatore Raffa, Roberta Di Rocco, Michela Roberto, Annalisa Milano, Angelo Zullo, Laura Leone, Danilo Ranieri, Francesca Mazzetta, Emanuela Medda, Ida Sarcina, Viola Barucca, Chiara D'Antonio, Valeria Durante, Mario Ferri, Maria Rosaria Torrisi, Paolo Marchetti

Istituto Dermopatico dell'Immacolata , IDI

Research output: Contribution to journal › Article › peer-review

Abstract

Background & Aims: Data on the potential of circulating tumor cells (CTC) count in predicting overall survival (OS) in patients with colorectal cancer are timely and worthy of interest. This study aimed to evaluate the prognostic role of CTC count in both localized and metastatic colorectal cancer patients. Methods: Consecutive patients with histological diagnosis of colorectal cancer were enrolled. CTC count was performed, by using a quantitative immunofluorescence method, at baseline (T0) and 1 month following start of chemotherapy (T1). A CTC count

Original language	English
Pages (from-to)	279-284
Number of pages	6
Journal	Journal of Gastrointestinal and Liver Diseases
Volume	23
Issue number	3
DOIs	https://doi.org/10.1543/jgld.2014.1121
Publication status	Published - 2014

Keywords

Circulating tumor cells
Colorectal cancer
Predictive value
Survival

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1543/jgld.2014.1121

Fingerprint Dive into the research topics of 'Circulating tumor cells count predicts survival in colorectal cancer patients'. Together they form a unique fingerprint.

Cite this

Romiti, A., Raffa, S., Di Rocco, R., Roberto, M., Milano, A., Zullo, A., Leone, L., Ranieri, D., Mazzetta, F., Medda, E., Sarcina, I., Barucca, V., D'Antonio, C., Durante, V., Ferri, M., Torrisi, M. R., & Marchetti, P. (2014). Circulating tumor cells count predicts survival in colorectal cancer patients. Journal of Gastrointestinal and Liver Diseases, 23(3), 279-284. https://doi.org/10.1543/jgld.2014.1121

Circulating tumor cells count predicts survival in colorectal cancer patients. / Romiti, Adriana; Raffa, Salvatore; Di Rocco, Roberta; Roberto, Michela; Milano, Annalisa; Zullo, Angelo; Leone, Laura; Ranieri, Danilo; Mazzetta, Francesca; Medda, Emanuela; Sarcina, Ida; Barucca, Viola; D'Antonio, Chiara; Durante, Valeria; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo.

In: Journal of Gastrointestinal and Liver Diseases, Vol. 23, No. 3, 2014, p. 279-284.

Research output: Contribution to journal › Article › peer-review

Romiti, A, Raffa, S, Di Rocco, R, Roberto, M, Milano, A, Zullo, A, Leone, L, Ranieri, D, Mazzetta, F, Medda, E, Sarcina, I, Barucca, V, D'Antonio, C, Durante, V, Ferri, M, Torrisi, MR & Marchetti, P 2014, 'Circulating tumor cells count predicts survival in colorectal cancer patients', Journal of Gastrointestinal and Liver Diseases, vol. 23, no. 3, pp. 279-284. https://doi.org/10.1543/jgld.2014.1121

Romiti, Adriana ; Raffa, Salvatore ; Di Rocco, Roberta ; Roberto, Michela ; Milano, Annalisa ; Zullo, Angelo ; Leone, Laura ; Ranieri, Danilo ; Mazzetta, Francesca ; Medda, Emanuela ; Sarcina, Ida ; Barucca, Viola ; D'Antonio, Chiara ; Durante, Valeria ; Ferri, Mario ; Torrisi, Maria Rosaria ; Marchetti, Paolo. / Circulating tumor cells count predicts survival in colorectal cancer patients. In: Journal of Gastrointestinal and Liver Diseases. 2014 ; Vol. 23, No. 3. pp. 279-284.

@article{850bb7bea59f484999bb1450151a920b,

title = "Circulating tumor cells count predicts survival in colorectal cancer patients",

abstract = "Background & Aims: Data on the potential of circulating tumor cells (CTC) count in predicting overall survival (OS) in patients with colorectal cancer are timely and worthy of interest. This study aimed to evaluate the prognostic role of CTC count in both localized and metastatic colorectal cancer patients. Methods: Consecutive patients with histological diagnosis of colorectal cancer were enrolled. CTC count was performed, by using a quantitative immunofluorescence method, at baseline (T0) and 1 month following start of chemotherapy (T1). A CTC count ",

keywords = "Circulating tumor cells, Colorectal cancer, Predictive value, Survival",

author = "Adriana Romiti and Salvatore Raffa and {Di Rocco}, Roberta and Michela Roberto and Annalisa Milano and Angelo Zullo and Laura Leone and Danilo Ranieri and Francesca Mazzetta and Emanuela Medda and Ida Sarcina and Viola Barucca and Chiara D'Antonio and Valeria Durante and Mario Ferri and Torrisi, {Maria Rosaria} and Paolo Marchetti",

year = "2014",

doi = "10.1543/jgld.2014.1121",

language = "English",

volume = "23",

pages = "279--284",

journal = "Journal of Gastrointestinal and Liver Diseases",

issn = "1841-8724",

publisher = "Romanian Society of Gastroenterology",

number = "3",

}

TY - JOUR

T1 - Circulating tumor cells count predicts survival in colorectal cancer patients

AU - Romiti, Adriana

AU - Raffa, Salvatore

AU - Di Rocco, Roberta

AU - Roberto, Michela

AU - Milano, Annalisa

AU - Zullo, Angelo

AU - Leone, Laura

AU - Ranieri, Danilo

AU - Mazzetta, Francesca

AU - Medda, Emanuela

AU - Sarcina, Ida

AU - Barucca, Viola

AU - D'Antonio, Chiara

AU - Durante, Valeria

AU - Ferri, Mario

AU - Torrisi, Maria Rosaria

AU - Marchetti, Paolo

PY - 2014

Y1 - 2014

N2 - Background & Aims: Data on the potential of circulating tumor cells (CTC) count in predicting overall survival (OS) in patients with colorectal cancer are timely and worthy of interest. This study aimed to evaluate the prognostic role of CTC count in both localized and metastatic colorectal cancer patients. Methods: Consecutive patients with histological diagnosis of colorectal cancer were enrolled. CTC count was performed, by using a quantitative immunofluorescence method, at baseline (T0) and 1 month following start of chemotherapy (T1). A CTC count

AB - Background & Aims: Data on the potential of circulating tumor cells (CTC) count in predicting overall survival (OS) in patients with colorectal cancer are timely and worthy of interest. This study aimed to evaluate the prognostic role of CTC count in both localized and metastatic colorectal cancer patients. Methods: Consecutive patients with histological diagnosis of colorectal cancer were enrolled. CTC count was performed, by using a quantitative immunofluorescence method, at baseline (T0) and 1 month following start of chemotherapy (T1). A CTC count

KW - Circulating tumor cells

KW - Colorectal cancer

KW - Predictive value

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84906883983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906883983&partnerID=8YFLogxK

U2 - 10.1543/jgld.2014.1121

DO - 10.1543/jgld.2014.1121

M3 - Article

VL - 23

SP - 279

EP - 284

JO - Journal of Gastrointestinal and Liver Diseases

JF - Journal of Gastrointestinal and Liver Diseases

SN - 1841-8724

IS - 3

ER -